A Singhakowinta
Overview
Explore the profile of A Singhakowinta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huan S, Pazdur R, Singhakowinta A, Samal B, VAITKEVICIUS V
Cancer
. 1989 Feb;
63(3):419-22.
PMID: 2912520
Low-dose continuous infusion 5-fluorouracil (LDCI-FU) was administered to 28 women with advanced breast carcinoma. Daily doses ranged from 175 to 250 mg/m2. The LDCI-FU was delivered continuously until the appearance...
2.
Martino S, Ratanatharathorn V, SAMAL B, Singhakowinta A, Haas C
Cancer Invest
. 1988 Jan;
6(3):289-91.
PMID: 3167612
Seventeen patients with metastatic breast cancer who had failed prior chemotherapy were treated with intravenous AZQ at a dose of 15-20 mg/m2 weekly for four consecutive weeks followed by a...
3.
Palutke W, Crane L, WENTWORTH B, GEIGER J, Cardozo L, Singhakowinta A, et al.
Am J Clin Pathol
. 1986 Sep;
86(3):348-51.
PMID: 3751997
Legionella feeleii has been implicated by serologic studies as the causative agent in an outbreak of Pontiac fever and has been recovered from an institutional water source. Pneumonia caused by...
4.
Martino S, Singhakowinta A
Cancer Treat Rep
. 1984 Jul;
68(7-8):1057-8.
PMID: 6744344
No abstract available.
5.
Martino S, SAMAL B, Singhakowinta A, Yoshida S, Mackenzie M, Jain J, et al.
J Cancer Res Clin Oncol
. 1984 Jan;
108(3):354-6.
PMID: 6439724
Thirty-six (36) women with metastatic breast cancer refractory to conventional therapies were treated with cis-diamminedichloroplatinum II. Two dose schedules were used sequentially. The first 15 patients received platinum at a...
6.
Martino S, SAMAL B, Singhakowinta A
Cancer Treat Rep
. 1983 Mar;
67(3):305-6.
PMID: 6831478
No abstract available.
7.
Brooks S, Singhakowinta A
Spec Top Endocrinol Metab
. 1982 Jan;
4:29-67.
PMID: 6763780
No abstract available.
8.
Reed M, VAITKEVICIUS V, Al-Sarraf M, Vaughn C, Singhakowinta A, Izbicki R, et al.
Cancer
. 1981 Jan;
47(2):402-9.
PMID: 6257376
Ten-year results are presented of 124 patients with malignancy apparently limited to the distribution of the hepatic artery, treated to prospective protocol with continuous infusion of 5-FUdR through an hepatic...
9.
Singhakowinta A, Saunders D, Brooks S, Samal B, VAITKEVICIUS V
Cancer
. 1980 Dec;
46(12 Suppl):2932-8.
PMID: 7448740
Patients with ER positive primary tumors usually have initial metastases at the more favorable sites. Twelve out of 14 patients with ER positive had first site of metastases in either...
10.
Brooks S, Saunders D, Singhakowinta A, VAITKEVICIUS V
Cancer
. 1980 Dec;
46(12 Suppl):2775-8.
PMID: 7448719
The levels of estrogen (E2R) and progesterone (PgR) receptors in 165 breast tumor biopsies have been determined. Seventy-seven percent of the specimens contained significant levels of E2R; 38.2% were positive...